M2™ Platform Recognized for the Significant Innovation that it Provides to the Pre-Clinical Imaging Marketplace
TORONTO, Canada, SHOHAM, Israel, Jan. 2, 2012 /CNW/ - The Scientist today unveiled the Top 10 Innovations of 2011 and selected Aspect Imaging's M2™ compact high-performance MRI imaging system as one the winners of this award. The Scientist invited members of the life science community to submit descriptions of exciting tools that made an impact in research this year and asked a panel of expert judges to evaluate the technologies. "The 2011 winners represent an exceptional combination of ingenuity and technical advances," said Mary Beth Aberlin, Editor-in-Chief of The Scientist.
"We are thrilled that The Scientist and their expert panel selected our M2 imaging platform as one of the 'Top 10 Innovations' in life science," says Uri Rapoport, Aspect Imaging's Founder and CEO. "With the rapid adoption of our technology and the growing use of our M2 MRI system globally to quantify biomarkers in vivo, we are most proud of the new insights that our customers in research and drug development are deriving by using our M2 platform. This award is further recognition as to the value MRI and most specifically - - the M2 high-performance compact MRI system - - is providing to the life scientist to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response in vivo".
Full details on The Scientist and its announcement of the winners of the "Top 10 Innovations of 2011" can be found at http://the-scientist.com/2012/01/01/top-ten-innovations-2011/.
About Aspect Imaging:
Aspect Imaging (www.aspectimaging.com) is the world's leader in high-performance compact MRI imaging systems for preclinical, clinical and advanced industrial applications. In preclinical research, Aspect's M2™ platform and suite of products enables academic researchers and pharmaceutical companies to harness the power and insights of MRI but without the cost, complexity and technical burden of traditional MRI systems. With Aspect's integrated and simple-to-use platform, researchers can derive deep insights into their biological questions quickly, easily and cost-effectively - - and all with the push of a button. As the system has no fringe magnetic field, the M2 can be placed anywhere in a working lab including at a scientist's benchtop. The M2™ platform is used by leading institutions for a broad range of in vivo, ex vivo and in vitro applications including high-resolution 3D anatomical, molecular, functional and multi-modality imaging. The Aspect high-performance MRI system is used to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response.
For further information: